Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keurig Dr Pepper Inc.'s SEC filings document operating results, governance, material events, and capital-structure matters for its beverage and coffee businesses. Form 8-K reports include quarterly and full-year financial results, outlook updates, material agreements, completed acquisition-related events, and other current-report disclosures tied to the company's refreshment beverage portfolio and Keurig coffee platform.
Proxy filings describe shareholder voting matters, board governance, executive compensation, and annual meeting proposals. The filing record also covers security-structure and capital disclosures, risk and financial reporting topics, and governance changes relevant to a public operating company with owned, licensed, and partner beverage and coffee brands.
Newlands William A reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director William A. Newlands received a grant of 6,062 restricted stock units on March 4, 2026. The units were awarded at a price of $0.00 per unit and increased his directly owned restricted stock unit holdings to 6,062.
According to the terms, these restricted stock units are subject to vesting conditions and are scheduled to vest on March 4, 2031. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock when vesting occurs.
Sandler Debra A. reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Debra A. Sandler received a grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no cash cost per unit.
Subject to vesting conditions and exceptions, the restricted stock units are scheduled to vest on March 4, 2031, with each unit representing a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting.
Keurig Dr Pepper Inc. director Michael G. Van de Ven reported an equity compensation grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no exercise price and increase his directly held derivative position to 6,062 units.
According to the footnote, the restricted stock units vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock once vesting requirements are met, so this filing reflects a long‑term incentive award rather than an open‑market share purchase.
Boston Oray reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Boston Oray received a grant of 6,062 restricted stock units of company stock. According to the terms, these units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock when it vests.
Whiting Lawson E reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Lawson E. Whiting reported receiving a grant of 6,062 restricted stock units on March 4, 2026. The award was recorded at a price of $0.00 per unit, reflecting a compensatory grant rather than an open-market purchase.
According to the terms, these 6,062 restricted stock units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting, so no shares are issued until the vesting requirements are met.
Keurig Dr Pepper Inc. director Robert S. Singer reported equity compensation activity involving restricted stock units and common shares. On March 4, 2026, he received a grant of 6,062 restricted stock units, each representing the right to receive one share of common stock upon future vesting, currently scheduled for March 4, 2031 subject to vesting conditions.
On March 3, 2026, 5,226 restricted stock units previously granted on March 3, 2021 fully vested and were converted into 5,226 shares of common stock on a one-for-one basis under the company’s Omnibus Stock Incentive Plan of 2019. Following these transactions, he holds 47,829 shares of common stock directly and 12,499 shares indirectly through the Robert Singer 2005 Insurance Trust.
Keurig Dr Pepper Inc. director Pamela H. Patsley reported equity compensation activity involving restricted stock units and common shares. On March 4, 2026, she received a grant of 10,392 restricted stock units, each representing a contingent right to one share of common stock, which are scheduled to vest on March 4, 2031 subject to vesting conditions.
On March 3, 2026, 5,226 restricted stock units granted on March 3, 2021 fully vested and were converted into 5,226 shares of common stock on a one-for-one basis under the Omnibus Stock Incentive Plan of 2019. After these transactions, she directly owned 44,992 shares of common stock and 10,392 restricted stock units.
Keurig Dr Pepper Inc. director Juliette Hickman reported equity compensation transactions involving restricted stock units. On March 3, 2026, 5,226 RSUs granted in 2021 fully vested and were exercised, converting into 5,226 shares of common stock on a one-for-one basis. On March 4, 2026, she received a new grant of 6,062 RSUs, which are scheduled to vest on March 4, 2031, subject to vesting conditions, with each unit representing the right to receive one share of common stock upon vesting.
Keurig Dr Pepper director Robert James Gamgort reported equity award activity involving restricted stock units and common shares. On March 2 and 3, he exercised several batches of restricted stock units, converting 30,699, 82,481, and 24,346 RSUs into common stock at no cash exercise price under the company’s Omnibus Stock Incentive Plan.
To cover applicable tax obligations upon vesting, he disposed of 12,081 and 42,038 common shares through share withholding transactions at prices of $29.57 and $29.97 per share, respectively, which are characterized as tax-withholding dispositions rather than open‑market sales. After these transactions, he directly held 1,942,875 common shares and also reported indirect ownership of additional shares held by 2024 and 2025 Trusts.
Keurig Dr Pepper Inc. filed an initial insider ownership report for Amie Thuener O'Toole, who is listed as a director of the company. This Form 3 filing establishes her reporting status as an insider. The data provided does not show any share transactions or holdings details.